Transplantation of human umbilical cord blood-derived mesenchymal stem cells or their conditioned medium prevents bone loss in ovariectomized nude mice

Tissue Engineering - Part A

Volumn 19, Issue 5-6, 2013, Pages 685-696

  An, Jee Hyun ^a   Park, Hyojung ^a   Song, Jung Ah ^a   Ki, Kyung Ho ^a   Yang, Jae Yeon ^a   Choi, Hyung Jin ^a   Cho, Sun Wook ^a   Kim, Sang Wan ^a   Kim, Seong Yeon ^a   Yoo, Jeong Joon ^a   Baek, Wook Young ^b   Kim, Jung Eun ^b   Choi, Soo Jin ^c   Oh, Wonil ^c   Shin, Chan Soo ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c MEDIPOST Co Ltd   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; BONE; COMPUTERIZED TOMOGRAPHY; FLOWCHARTING; MAMMALS; PHOSPHATASES; STEM CELLS; TISSUE; VEHICLES;

ALKALINE PHOSPHATASE ACTIVITY; BONE FORMATION; BONE LOSS; BONE MASS; BONE MINERAL DENSITY; BONE TISSUE; COLLAGEN TYPE 1; CONDITIONED MEDIUM; ENGRAFTMENT; HISTOMORPHOMETRIC ANALYSIS; HUMAN BONES; HUMAN DERMAL FIBROBLASTS; HUMAN UMBILICAL CORD; IN-VITRO; MESENCHYMAL STEM CELL; MICROCOMPUTED TOMOGRAPHY; MRNA EXPRESSION; NEW SOURCES; NUDE MICE; OSTEOCLASTIC DIFFERENTIATION; OSTERIX; PARACRINE; PROCOLLAGEN; STEM CELL THERAPY; UMBILICAL CORD BLOOD;

CELL CULTURE;

MUS; MUS MUSCULUS;

BIOLOGICAL MARKER; CULTURE MEDIUM;

ANIMAL; BLOOD; BONE DENSITY; BONE REMODELING; CELL DIFFERENTIATION; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECTS; FEMALE; FETUS BLOOD; FLOW CYTOMETRY; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; MOUSE; NUDE MOUSE; OSTEOBLAST; OSTEOLYSIS; OVARIECTOMY; PATHOLOGY; PATHOPHYSIOLOGY; PHARMACOLOGY; PREVENTION AND CONTROL; RADIOGRAPHY; SPINE; THERAPY; TIBIA; ARTICLE; DRUG EFFECT;

ANIMALS; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; BONE RESORPTION; CELL DIFFERENTIATION; CULTURE MEDIA, CONDITIONED; FEMALE; FETAL BLOOD; FLOW CYTOMETRY; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, NUDE; OSTEOBLASTS; OVARIECTOMY; SPINE; TIBIA;

EID: 84873401330     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0047     Document Type: Article

References (48)

1. Burge, R., Dawson-Hughes, B., Solomon, D.H., Wong, J.B., King, A., and Tosteson, A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22, 465, 2007
2. Body, J.J., Bergmann, P., Boonen, S., Boutsen, Y., Devogelaer, J.P., Goemaere, S., et al. Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club. Osteo-poros Int 21, 1657, 2010
3. Schilcher, J., Michaelsson, K., and Aspenberg, P. Bispho-sphonate use and atypical fractures of the femoral shaft. N Engl J Med 364, 1728, 2011
4. Ruggiero, S.L. Bisphosphonate-related osteonecrosis of the jaw: an overview. Ann N Y Acad Sci 1218, 38, 2011
5. Orwoll, E.S., Scheele, W.H., Paul, S., Adami, S., Syversen, U., Diez-Perez, A., et al. The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis. J Bone Miner Res 18, 9, 2003
6. Miyauchi, A., Matsumoto, T., Shigeta, H., Tsujimoto, M., Thiebaud, D., and Nakamura, T. Effect of teriparatide on bone mineral density and biochemical markers in Japanese women with postmenopausal osteoporosis: a 6-month dose-response study. J Bone Miner Metab 26, 624, 2008
7. Florenzano, F., and Minguell, J.J. Autologous mesenchymal stem cell transplantation after acute myocardial infarction. Am J Cardiol 95, 435, 2005
8. Imanishi, Y., Saito, A., Komoda, H., Kitagawa-Sakakida, S., Miyagawa, S., Kondoh, H., et al. Allogenic mesenchymal stem cell transplantation has a therapeutic effect in acute myocardial infarction in rats. J Mol Cell Cardiol 44, 662, 2008
9. Jeong, S.W., Chu, K., Jung, K.H., Kim, S.U., Kim, M., and Roh, J.K. Human neural stem cell transplantation promotes functional recovery in rats with experimental intracerebral hemorrhage. Stroke 34, 2258, 2003
10. Lee, H.J., Kim, K.S., Kim, E.J., Choi, H.B., Lee, K.H., Park, I.H., et al. Brain transplantation of immortalized human eural stem cells promotes functional recovery in mouse intracerebral hemorrhage stroke model. Stem Cells 25, 1204, 2007
11. Voltarelli, J.C., Couri, C.E., Stracieri, A.B., Oliveira, M.C., Moraes, D.A., Pieroni, F., et al. Autologous non-myeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 297, 1568, 2007
12. Bhansali, A., Upreti, V., Khandelwal, N., Marwaha, N., Gupta, V., Sachdeva, N., et al. Efficacy of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus. Stem Cells Dev 18, 1407, 2009
13. Mobasheri, A., Csaki, C., Clutterbuck, A.L., Rahmanzadeh, M., and Shakibaei, M. Mesenchymal stem cells in connective tissue engineering and regenerative medicine: applications in cartilage repair and osteoarthritis therapy. Histol Histo-pathol 24, 347, 2009
14. Kumar, S., Wan, C., Ramaswamy, G., Clemens, T.L., and Ponnazhagan, S. Mesenchymal stem cells expressing osteo-genic and angiogenic factors synergistically enhance bone formation in a mouse model of segmental bone defect. Mol Ther 18, 1026, 2010
15. Zhao, M., Zhou, J., Li, X., Fang, T., Dai, W., Yin, W., et al. Repair of bone defect with vascularized tissue engineered bone graft seeded with mesenchymal stem cells in rabbits. Microsurgery 31, 130, 2011
16. Kim, D., Cho, S.W., Her, S.J., Yang, J.Y., Kim, S.W., Kim, S.Y., et al. Retrovirus-mediated gene transfer of receptor activator of nuclear factor-kappaB-Fc prevents bone loss in ovariectomized mice. Stem Cells 24, 1798, 2006
17. Cho, S.W., Sun, H.J., Yang, J.Y., Jung, J.Y., An, J.H., Cho, H.Y., et al. Transplantation of mesenchymal stem cells overexpressing RANK-Fc or CXCR4 prevents bone loss in ovariectomized mice. Mol Ther 17, 1979, 2009
18. Timmers, L., Lim, S.K., Arslan, F., Armstrong, J.S., Hoefer, I.E., Doevendans, P.A., et al. Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res 1, 129, 2007
19. Timmers, L., Lim, S.K., Hoefer, I.E., Arslan, F., Lai, R.C., van Oorschot, A.A., et al. Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem Cell Res 6, 206, 2011
20. Chen, L., Tredget, E.E., Wu, PY., and Wu, Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 3, e1886, 2008
21. Walter, M.N., Wright, K.T., Fuller, H.R., MacNeil, S., and Johnson, W.E. Mesenchymal stem cell-conditioned medium accelerates skin wound healing: an in vitro study of fibro-blast and keratinocyte scratch assays. Exp Cell Res 316,1271, 2010
22. Lim, H.C., Lee, S.T., Chu, K., Joo, K.M., Kang, L., Im, W.S., et al. Neuroprotective effect of neural stem cell-conditioned media in in vitro model of Huntington's disease. Neurosci Lett 435, 175, 2008
23. Mendes, S.C., Tibbe, J.M., Veenhof, M., Bakker, K., Both, S., Platenburg, P.P., et al. Bone tissue-engineered implants using human bone marrow stromal cells: effect of culture condi-tions and donor age. Tissue Eng 8, 911, 2002
24. Stenderup, K., Justesen, J., Clausen, C., and Kassem, M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33, 919, 2003
25. Stolzing, A., Jones, E., McGonagle, D., and Scutt, A. Age-related changes in human bone marrow-derived mesen-chymal stem cells: consequences for cell therapies. Mech Ageing Dev 129, 163, 2008
26. Tisato, V., Naresh, K., Girdlestone, J., Navarrete, C., and Dazzi, F. Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease. Leukemia 21, 1992, 2007
27. Majhail, N.S., Brunstein, C.G., Tomblyn, M., Thomas, A.J., Miller, J.S., Arora, M., et al. Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbil-ical cord blood is safe and effective for patients without a matched related donor. Biol Blood Marrow Transplant 14, 282, 2008
28. Rebelatto, C.K., Aguiar, A.M., Moretao, M.P., Senegaglia, A.C., Hansen, P., Barchiki, F., et al. Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp Biol Med (Maywood) 233, 901, 2008
29. Guillot, P.V., De Bari, C., Dell'Accio, F., Kurata, H., Polak, J., and Fisk, N.M. Comparative osteogenic transcription pro-filing of various fetal and adult mesenchymal stem cell sources. Differentiation 76, 946, 2008
30. Yang, S.E., Ha, C.W., Jung, M., Jin, H.J., Lee, M., Song, H., et al. Mesenchymal stem/progenitor cells developed in cul-tures from UC blood. Cytotherapy 6, 476, 2004
31. Liu, Y., Ding, Y., Ma, P., Wu, Z., Duan, H., Liu, Z., et al. Enhancement of long-term proliferative capacity of rabbit corneal epithelial cells by embryonic stem cell condi-tioned medium. Tissue Eng Part C Methods 16, 793, 2010
32. Yoo, J.J., Song, W.S., Koo, K.H., Yoon, K.S., and Kim, H.J. Osteogenic abilities of bone marrow stromal cells are not defective in patients with osteonecrosis. Int Orthop 33, 867, 2009
33. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999
34. Bellino, F.L. Nonprimate animal models of menopause: workshop report. Menopause 7, 14, 2000
35. Erben, R.G. Embedding of bone samples in methylmetha-crylate: an improved method suitable for bone histomor-phometry, histochemistry, and immunohistochemistry. J Histochem Cytochem 45, 307, 1997
36. Becker, H.M., Chen, M., Hay, J.B., and Cybulsky, M.I. Tracking of leukocyte recruitment into tissues of mice by in situ labeling of blood cells with the fluorescent dye CFDA SE. J Immunol Methods 286, 69, 2004
37. Chou, MY., Yan, D., Jafarov, T., and Everett, E.T. Modula-tion of murine bone marrow-derived CFU-F and CFU-OB by in vivo bisphosphonate and fluoride treatments. Orthodont Craniofac Res 12, 141, 2009
38. An, J.H., Yang, J.Y., Ahn, BY., Cho, S.W., Jung, J.Y., Cho, H.Y., et al. Enhanced mitochondrial biogenesis contributes to Wnt induced osteoblastic differentiation of C3H10T1/2 cells. Bone 47, 140, 2010
39. Cho, S.W., Yang, J.Y., Her, S.J., Choi, H.J., Jung, J.Y., Sun, H.J., et al. Osteoblast-targeted overexpression of PPARgam-ma inhibited bone mass gain in male mice and accelerated ovariectomy-induced bone loss in female mice. J Bone Miner Res 26, 1939, 2011
40. Oh, W., Kim, D.S., Yang, Y.S., and Lee, J.K. Immunological properties of umbilical cord blood-derived mesenchymal stromal cells. Cell Immunol 251, 116, 2008
41. Cho, S.W., Sun, H.J., Yang, J.Y., Jung, J.Y., Choi, H.J., An, J.H., et al. Human adipose tissue-derived stromal cell ther-apy prevents bone loss in ovariectomized nude mouse. Tissue Eng Part A 18, 1067, 2012
42. Nakanishi, C., Yamagishi, M., Yamahara, K., Hagino, I., Mori, H., Sawa, Y., et al. Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells. Biochem Biophys Res Commun 374, 11, 2008
43. Jung, J., Moon, N., Ahn, J.Y., Oh, E.J., Kim, M., Cho, C.S., et al. Mesenchymal stromal cells expanded in human allo-genic cord blood serum display higher self-renewal and enhanced osteogenic potential. Stem Cells Dev 18,559, 2009
44. Bonewald, L.F. The amazing osteocyte. J Bone Miner Res 26, 229, 2011
45. Barragan-Adjemian, C., Nicolella, D., Dusevich, V., Dallas, M.R., Eick, J.D., and Bonewald, L.F. Mechanism by which MLO-A5 late osteoblasts/early osteocytes mineralize in culture: similarities with mineralization of lamellar bone. Calcif Tissue Int 79, 340, 2006
46. Dunstan, C.R., Evans, R.A., Hills, E., Wong, SY., and Higgs, R.J. Bone death in hip fracture in the elderly. Calcif Tissue Int 47, 270, 1990
47. Wong, SY., Evans, R.A., Needs, C., Dunstan, C.R., Hills, E., and Garvan, J. The pathogenesis of osteoarthritis of the hip. Evidence for primary osteocyte death. Clin Orthop Relat Res 214, 305, 1987
48. Weinstein, R.S., Nicholas, R.W., and Manolagas, S.C Apoptosis of osteocytes in glucocorticoid-induced osteo-necrosis of the hip. J Clin Endocrinol Metab 85, 2907, 2000